Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Alexza Pharmaceuticals Inc. | f58240exv23w1.htm |
| EX-21.1 - EX-21.1 - Alexza Pharmaceuticals Inc. | f58240exv21w1.htm |
| EX-31.2 - EX-31.2 - Alexza Pharmaceuticals Inc. | f58240exv31w2.htm |
| EX-31.1 - EX-31.1 - Alexza Pharmaceuticals Inc. | f58240exv31w1.htm |
| EX-10.45 - EX-10.45 - Alexza Pharmaceuticals Inc. | f58240exv10w45.htm |
| EX-10.47 - EX-10.47 - Alexza Pharmaceuticals Inc. | f58240exv10w47.htm |
| EX-10.46 - EX-10.46 - Alexza Pharmaceuticals Inc. | f58240exv10w46.htm |
| 10-K - FORM 10-K - Alexza Pharmaceuticals Inc. | f58240e10vk.htm |
Exhibit 32.1
CERTIFICATION
Pursuant to the requirement set forth in
Rule 13a-14(b)
of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and Section 1350 of
Chapter 63 of Title 18 of the United States Code
(18 U.S.C. § 1350), Thomas B. King, President and
Chief Executive Officer of Alexza Pharmaceuticals, Inc. (the
“Company”), and August J. Moretti, the Senior Vice
President and Chief Financial Officer of the Company, each
hereby certifies that, to the best of his knowledge:
1. The Company’s Annual Report on
Form 10-K
for the period ended December 31, 2010, to which this
Certification is attached as Exhibit 32.1 (the “Annual
Report”), fully complies with the requirements of
Section 13(a) or Section 15(d) of the Exchange
Act; and
2. The information contained in the Annual Report fairly
presents, in all material respects, the financial condition and
results of operations of the Company.
In Witness Whereof, the undersigned have set their hands
hereto as of the 15th day of March, 2011.
|
/s/ Thomas
B. King
|
/s/ August
J. Moretti
|
|
|
Thomas B. King
|
August J. Moretti | |
|
President and Chief Executive Officer
|
Senior Vice President, Chief Financial Officer, General Counsel and Secretary |
This certification accompanies the
Form 10-K
to which it relates, is not deemed filed with the Securities and
Exchange Commission and is not to be incorporated by reference
into any filing of Alexza Pharmaceuticals, Inc. under the
Securities Act of 1933, as amended, or the Securities Exchange
Act of 1934, as amended (whether made before or after the date
of the
Form 10-K),
irrespective of any general incorporation language contained in
such filing.